Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02152462 · ClinicalTrials.gov registry record · Phase 2
Exergaming Intervention and Breast Cancer Biomarkers in Black Women
A Phase 2 study, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT02152462 is a Phase 2 study that has completed, run by Georgetown University. The registered enrollment target is 150 participants.
The verdict
NCT02152462, a Phase 2 study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
Overview: This is a 6 month, two-arm randomized clinical trial using comparing exergaming to a control group. The investigators will randomize Black sedentary overweight/obese women to Wii Fit exercise (n=50) or the control arm (n=50). Women in the Wii Fit exercise group will come to the Georgetown community-based exercise facility 3 days/wk. The control group will be asked to maintain their current daily activities and not to exercise for the duration of the study. Based on the investigators previous findings that women who engage in 75-150 mins/wk of brisk walking had an 18% decreased risk of breast cancer, the investigators will target this level of activity in the investigators intervention arm. Also, this 150 min/week of physical activity meets the current recommendations of the American College of Sports Medicine (ACSM) and the US Department of Health and Human Services for healthy individuals and is in line with recommendation of the American Cancer Society (ACS) for cancer prevention.
Interventions
- OTHER Exergaming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-12 |
| Est. Completion | 2019-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02152462
The ClinicalTrials.gov registry entry for NCT02152462 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exergaming is the first listed.
NCT02152462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02152462 about?
NCT02152462 is a clinical study titled "Exergaming Intervention and Breast Cancer Biomarkers in Black Women". Overview: This is a 6 month, two-arm randomized clinical trial using comparing exergaming to a control group. The investigators will randomize Black sedentary overweight/obese women to Wii Fit exercise (n=50) or the control arm (n=50). Women in the Wii Fit exercise group will come to the Georgetown ...
What is the current status of trial NCT02152462?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2012-12. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02152462?
The interventions under investigation include: Exergaming (OTHER).
Who is sponsoring clinical trial NCT02152462?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.